WOONSOCKET, R.I., Sept. 17, 2018 /PRNewswire/ -- CVS Health [NYSE:
CVS] President and CEO Larry Merlo
will share his insights on the accelerated pace of change in health
care and vision for transforming America's $3.6 trillion health care system during a
gathering of Town Hall Los Angeles, the city's oldest and largest
public speaking forums for presenting solutions to the most
relevant issues affecting the Los
Angeles community.
"Today's health care system has become increasingly fragmented
and too complex for people to navigate and afford. And without true
innovation, more Americans will simply be without health care in
the future," said Merlo. "I'm looking forward to sharing with
leaders from across Los Angeles
the many ways our company is transforming health care today, and
our even more ambitious journey to lead the change that is needed
more broadly in American health care in the future."
During his remarks, Merlo will highlight how the combination of
CVS Health and Aetna, one of the nation's leading diversified
health care benefits companies, will combine data-driven insights,
new digital technologies, and the convenience of local
community-based care to establish a new health care delivery model
that is easier to use, less expensive and puts consumers at the
center of their care.
Merlo is scheduled to make his remarks on Thursday, September 20, 11:30 a.m.-1:30 p.m., at the City Club of
Los Angeles. To attend the event,
visit Town Hall Los Angeles.
Town Hall Los Angeles is a non-profit, nonpartisan speaker's
forum, providing a vital platform for discussing and debating
today's most pressing issues. One of the Top 10 Leadership Forums
in the nation, Town Hall is dedicated to promoting civic
participation in the Los Angeles
community. In a world of sound bites, Town Hall embodies the values
of a democracy and the role of an engaged citizenry.
About CVS Health
CVS Health is a pharmacy innovation company helping people on
their path to better health. Through its more than 9,800 retail
locations, more than 1,100 walk-in medical clinics, a leading
pharmacy benefits manager with approximately 94 million plan
members, a dedicated senior pharmacy care business serving more
than one million patients per year, expanding specialty pharmacy
services, and a leading stand-alone Medicare Part D prescription
drug plan, the company enables people, businesses and communities
to manage health in more affordable and effective ways. This unique
integrated model increases access to quality care, delivers better
health outcomes and lowers overall health care costs. Find more
information about how CVS Health is shaping the future of health at
https://www.cvshealth.com.
Contacts:
Media Contact:
Joe Goode, 401-770-9820
Joseph.Goode@CVSHealth.com
Investor Relations:
Mike McGuire, 401-770-4050
Michael.McGuire@CVSHealth.com
No Offer or Solicitation
This communication is for informational purposes only and not
intended to and does not constitute an offer to subscribe for, buy
or sell, the solicitation of an offer to subscribe for, buy or sell
or an invitation to subscribe for, buy or sell any securities or
the solicitation of any vote or approval in any jurisdiction
pursuant to or in connection with the proposed transaction or
otherwise, nor shall there be any sale, issuance or transfer of
securities in any jurisdiction in contravention of applicable law.
No offer of securities shall be made except by means of a
prospectus meeting the requirements of Section 10 of the Securities
Act of 1933, as amended, and otherwise in accordance with
applicable law.
Additional Information and Where to Find It
In connection with the proposed transaction between CVS Health
Corporation ("CVS Health") and Aetna Inc. ("Aetna"), CVS Health
filed a registration statement on Form S-4 with the Securities and
Exchange Commission (the "SEC"), which includes a joint proxy
statement of CVS Health and Aetna that also constitutes a
prospectus of CVS Health. The registration statement was declared
effective by the SEC on February 9,
2018, and CVS Health and Aetna commenced mailing the
definitive joint proxy statement/prospectus to stockholders of CVS
Health and shareholders of Aetna on or about February 12, 2018, and the special meeting of the
stockholders of CVS Health and the shareholders of Aetna was held
on March 13, 2018. INVESTORS AND
SECURITY HOLDERS OF CVS HEALTH AND AETNA ARE URGED TO READ THE
DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS
FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY
CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and
security holders may obtain free copies of the registration
statement and the definitive joint proxy statement/prospectus and
other documents filed with the SEC by CVS Health or Aetna through
the website maintained by the SEC at http://www.sec.gov. Copies of
the documents filed with the SEC by CVS Health are available free
of charge within the Investors section of CVS Health's Web site at
http://www.cvshealth.com/investors or by contacting CVS
Health's Investor Relations Department at 800-201-0938. Copies of
the documents filed with the SEC by Aetna are available free of
charge on Aetna's internet website at http://www.Aetna.com or
by contacting Aetna's Investor Relations Department at
860-273-0896.
Cautionary Statement Regarding Forward-Looking
Statements
The Private Securities Litigation Reform Act of 1995 (the
"Reform Act") provides a safe harbor for forward-looking statements
made by or on behalf of CVS Health or Aetna. This communication may
contain forward-looking statements within the meaning of the Reform
Act. You can generally identify forward-looking statements by the
use of forward-looking terminology such as "anticipate," "believe,"
"can," "continue," "could," "estimate," "evaluate," "expect,"
"explore," "forecast," "guidance," "intend," "likely," "may,"
"might," "outlook," "plan," "potential," "predict," "probable,"
"project," "seek," "should," "view," or "will," or the negative
thereof or other variations thereon or comparable terminology.
These forward-looking statements are only predictions and involve
known and unknown risks and uncertainties, many of which are beyond
CVS Health's and Aetna's control.
Statements in this communication that are forward-looking,
including projections as to the closing date for the pending
acquisition of Aetna (the "transaction"), the extent of, and the
time necessary to obtain, the regulatory approvals required for the
transaction, the anticipated benefits of the transaction, the
impact of the transaction on CVS Health's and Aetna's businesses,
the expected terms and scope of the expected financing for the
transaction, the ownership percentages of CVS Health's common stock
of CVS Health stockholders and Aetna shareholders at closing, the
aggregate amount of indebtedness of CVS Health following the
closing of the transaction, CVS Health's expectations regarding
debt repayment and its debt to capital ratio following the closing
of the transaction, CVS Health's and Aetna's respective share
repurchase programs and ability and intent to declare future
dividend payments, the number of prescriptions used by people
served by the combined companies' pharmacy benefit business, the
synergies from the transaction, and CVS Health's, Aetna's and/or
the combined company's future operating results, are based on CVS
Health's and Aetna's managements' estimates, assumptions and
projections, and are subject to significant uncertainties and other
factors, many of which are beyond their control. In particular,
projected financial information for the combined businesses of CVS
Health and Aetna is based on estimates, assumptions and projections
and has not been prepared in conformance with the applicable
accounting requirements of Regulation S-X relating to pro forma
financial information, and the required pro forma adjustments have
not been applied and are not reflected therein. None of this
information should be considered in isolation from, or as a
substitute for, the historical financial statements of CVS Health
and Aetna. Important risk factors related to the transaction could
cause actual future results and other future events to differ
materially from those currently estimated by management, including,
but not limited to: the timing to consummate the proposed
transaction; the risk that a regulatory approval that may be
required for the proposed transaction is delayed, is not obtained
or is obtained subject to conditions that are not anticipated; the
risk that a condition to the closing of the proposed transaction
may not be satisfied; the outcome of litigation related to the
transaction; the ability to achieve the synergies and value
creation contemplated; CVS Health's ability to promptly and
effectively integrate Aetna's businesses; and the diversion of and
attention of management of both CVS Health and Aetna on
transaction-related issues.
In addition, this communication may contain forward-looking
statements regarding CVS Health's or Aetna's respective businesses,
financial condition and results of operations. These
forward-looking statements also involve risks, uncertainties and
assumptions, some of which may not be presently known to CVS Health
or Aetna or that they currently believe to be immaterial also may
cause CVS Health's or Aetna's actual results to differ materially
from those expressed in the forward-looking statements, adversely
impact their respective businesses, CVS Health's ability to
complete the transaction and/or CVS Health's ability to realize the
expected benefits from the transaction. Should any risks and
uncertainties develop into actual events, these developments could
have a material adverse effect on the transaction and/or CVS Health
or Aetna, CVS Health's ability to successfully complete the
transaction and/or realize the expected benefits from the
transaction. Additional information concerning these risks,
uncertainties and assumptions can be found in CVS Health's and
Aetna's respective filings with the SEC, including the risk factors
discussed in "Item 1.A. Risk Factors" in CVS Health's and Aetna's
most recent Annual Reports on Form 10-K, as updated by their
Quarterly Reports on Form 10-Q and future filings with the SEC.
You are cautioned not to place undue reliance on these
forward-looking statements. These forward-looking statements are
and will be based upon management's then-current views and
assumptions regarding future events and operating performance, and
are applicable only as of the dates of such statements. Neither CVS
Health nor Aetna assumes any duty to update or revise
forward-looking statements, whether as a result of new information,
future events or otherwise, as of any future date.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cvs-health-ceo-larry-merlo-to-discuss-transformational-change-in-health-care-at-town-hall-los-angeles-300713378.html
SOURCE CVS Health